EP Patent

EP0701449A1 — Process for the preparation of an oral solid dosage form containing diclofenac

Assigned to Novartis Pharma GmbH · Expires 1996-03-20 · 30y expired

What this patent protects

The invention relates to a novel advantageous process for the preparation of an oral solid dosage form containing diclofenac or a pharmaceutically acceptable salt thereof. The dosage form is obtainable by direct compression of an inclusion compound consisting of diclofenac, or a …

USPTO Abstract

The invention relates to a novel advantageous process for the preparation of an oral solid dosage form containing diclofenac or a pharmaceutically acceptable salt thereof. The dosage form is obtainable by direct compression of an inclusion compound consisting of diclofenac, or a salt thereof, with gamma -cyclodextrin. The inclusion compound itself is novel and is likewise an object of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
EP0701449A1
Jurisdiction
EP
Classification
—
Expires
1996-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Novartis Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.